Generation of Spheroids from Human Pluripotent Stem Cells
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 3:00 min • July 8th, 2025
Begin with colonies of human pluripotent stem cells or hPSCs attached to a suitable substrate in a culture medium.
Remove the medium. Add a neuronal medium containing specific inhibitors and incubate.
These inhibitors direct the maturation of hPSCs toward a neuronal lineage, forming neuroectodermal colonies. These are precursors to small, spherical structures called spheroids.
Remove the medium and wash with a salt buffer.
Incubate with a digestive enzyme to detach the colonies from the plate.
Add the neuronal medium to stop the enzymatic activity.
Collect the colonies and transfer them to a tube.
Allow them to settle, and then discard the supernatant.
Resuspend the colonies in a neuronal medium containing a growth factor.
Transfer the colonies to a multi-well plate and incubate.
This growth factor facilitates the self-organization and multiplication of neuroectodermal cells, leading them to form a spheroid.
To begin, plate the hPSC colonies on an hESC-qualified basement membrane matrix from one well of a 6-well plate at 60% confluency into three wells to achieve 20% to 30% density, and then, proceed with induction of 2D neuroectodermal colonies.
Add fresh N2 media supplemented with dual SMAD inhibitors daily to each well for the next 3 days. For generating 3D neuroectodermal spheroids from induced 2D neuroectodermal colonies, remove 2 milliliters of N2 medium from the 6-well plate, and wash one time with HBSS to ensure that all of the N2 medium is removed.
Add 1 milliliter of dispase to each colony-containing well. Incubate the plate for 20 to 25 minutes at 37 degrees Celsius, and check for colony detachment regularly. At the end of the incubation, to stop the activity of the dispase enzyme, add 1 milliliter of N2 medium to the well. Using a wide-bore P1000 pipette tip or a modified P1000 pipette tip cup with sterile scissors, transfer the colonies into a 15-milliliter tube, and allow the colony clumps to sink to the bottom of the tube with gravity.
Then, with a standard P1000 pipette tip, carefully remove the supernatant. Replace it with 1 milliliter of fresh N2 medium, and repeat washing thrice to ensure complete removal of dispase. After resuspending the cell clumps and N2 medium, transfer the cell suspension to one well of a 6-well plate, and add 40 nanograms per milliliter of bFGF.
Overview
This article outlines a protocol for differentiating human pluripotent stem cells (hPSCs) into neuroectodermal spheroids. The process involves the use of specific inhibitors and growth factors to guide the maturation and self-organization of stem cells.
Key Study Components
Area of Science
- Stem cell biology
- Neuroscience
- Cell culture techniques
Background
- Human pluripotent stem cells can differentiate into various cell types.
- Neuroectodermal cells are precursors to neurons and glial cells.
- Understanding the differentiation process is crucial for regenerative medicine.
- Spheroids mimic in vivo conditions better than 2D cultures.
Purpose of Study
- To develop a reliable method for generating neuroectodermal spheroids from hPSCs.
- To investigate the effects of growth factors on cell organization.
- To enhance the understanding of neuronal lineage specification.
Methods Used
- Culture of hPSCs on a suitable substrate.
- Use of neuronal medium with specific inhibitors for differentiation.
- Enzymatic detachment of colonies for spheroid formation.
- Incubation with growth factors to promote self-organization.
Main Results
- Successful formation of neuroectodermal colonies and spheroids.
- Demonstrated the role of growth factors in cell multiplication.
- Established a reproducible protocol for spheroid generation.
- Provided insights into the differentiation process of hPSCs.
Conclusions
- The protocol enables efficient generation of neuroectodermal spheroids.
- Growth factors significantly influence the self-organization of cells.
- This method can be applied in studies of neurodevelopment and disease modeling.
Frequently Asked Questions
Executive Industry Relevance
This protocol enables reproducible generation of neuroectodermal spheroids from human pluripotent stem cells, providing a scalable in vitro model for early neuronal differentiation. The approach supports target validation and mechanistic de-risking in neurodegenerative disease models by producing disease-relevant systems with defined cellular organization. It enhances predictive confidence in lead identification by offering a standardized platform for screening compounds affecting neurodevelopmental pathways.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through directed differentiation of hPSCs into neuroectodermal lineages using dual SMAD inhibitors.
- Operational Value: Provides a reproducible method to form spheroids, reducing variability in early target engagement studies.
- Predictive Value: Supports biological de-risking by generating disease-relevant systems that model early neuronal senescence and neurodevelopmental processes.
Screening & Assay Development
- Scientific Value: Produces uniform spheroids suitable for high-content imaging and phenotypic screening of compounds targeting neuronal maturation.
- Operational Value: Enables assay standardization through defined steps: inhibitor-mediated differentiation, enzymatic detachment, and bFGF-driven self-organization.
- Scalability: Supports multi-well plate formats, allowing parallel testing across concentrations and time points for lead optimization.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery to preclinical validation by modeling early stages of neuronal lineage specification relevant to neurodevelopmental disorders.
- Mechanistic De-risking: Allows assessment of compound effects on spheroid formation and growth, informing target engagement and pathway modulation.
- Biomarker Alignment: Facilitates evaluation of neuroectodermal markers as translational biomarkers for pathway activity in disease models.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from stem cell differentiation to functional assay readouts, supporting early target validation and lead identification stages.
- Discovery Biology: Supports hypothesis testing by enabling controlled differentiation of hPSCs into neuroectodermal colonies using specific inhibitors.
- Screening: Delivers assay-ready spheroids with consistent size and morphology, improving reproducibility in compound screening campaigns.
- Analytics: Generates quantitative outputs such as spheroid formation rate and size distribution, enabling comparison across experimental conditions.
- Translational Research: Connects to preclinical work by providing a human-relevant system to study neuronal senescence and differentiation dynamics.
- Enterprise Reuse: Establishes a scalable, modular platform adaptable to multiple targets and disease models within neuroscience portfolios.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence through biologically relevant 3D models that recapitulate early neuroectodermal organization.
- Operational Value: Enhances standardization and reproducibility via defined enzymatic detachment and growth factor supplementation steps.
- Strategic Value: Improves go/no-go decisions by reducing mechanistic ambiguity in early-stage neurodevelopmental target validation.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on effects on spheroid formation and cellular self-organization.
Implementation Considerations
- Requires expertise in stem cell culture and differentiation techniques, including handling of hPSCs and enzymatic reagents.
- Depends on consistent availability of neuronal medium, dual SMAD inhibitors, bFGF, and dispase for colony detachment.
- Necessitates standardized protocols across teams to ensure uniform spheroid quality and minimize batch-to-batch variability.
- Involves adaptation considerations when extending to other pluripotent stem cell lines or disease-specific genetic backgrounds.
- Limited by the need for careful monitoring of colony detachment timing to prevent over-digestion and maintain spheroid integrity.
Biopharma FAQs
Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Related Videos
0 Views
Three-Dimensional Motor Nerve Organoid Generation
Related Videos
0 Views
Brain Organoid Generation from Induced Pluripotent Stem Cells in Home-Made Mini Bioreactors
Related Videos
0 Views
Spheroid Generation from Cell Lines: A Three-Dimensional (3D) Cell Culture Method
Related Videos
0 Views
Generating and Maintaining Astrospheres Using Human Pluripotent Stem Cells
Related Videos
0 Views
Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol
Related Videos
0 Views
Serum Free Production of Three-dimensional Human Hepatospheres from Pluripotent Stem Cells
Related Videos
0 Views
Microfluidic Fabrication of Core-Shell Microcapsules carrying Human Pluripotent Stem Cell Spheroids
Related Videos
0 Views
Generation of Tissue Spheroids via a 3D Printed Stamp-Like Device
Related Videos
0 Views
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Related Videos
0 Views
Last updated: 29 August 2026